Preclinical Development of Genetically-Delivered Bevacizumab for Treatment of Wet Macular Degeneration Grant uri icon

Overview

date/time interval

  • February 1, 2013 - January 31, 2015

sponsor award ID

  • 1 R43 EY023108-01 EWOF

Affiliation